{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:49:42Z","timestamp":1789451382629,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jad.2012.09.023","type":"journal-article","created":{"date-parts":[[2012,10,18]],"date-time":"2012-10-18T04:53:54Z","timestamp":1350536034000},"page":"383-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Are subjects in treatment trials of panic disorder representative of patients in routine clinical practice? Results from a national sample"],"prefix":"10.1016","volume":"146","author":[{"given":"Nicolas","family":"Hoertel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Le Strat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"De Maricourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Limosin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Dubertret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2012.09.023_bib1","first-page":"402","article-title":"Comparison of Fluvoxamine alone, Fluvoxamine and cognitive psychotherapy and psychotherapy alone in the treatment of panic disorder in Kelantan\u2014implications for management by family doctors","volume":"55","author":"Azhar","year":"2000","journal-title":"Medical Journal of Malaysia"},{"key":"10.1016\/j.jad.2012.09.023_bib2","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.283.19.2529","article-title":"Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial","volume":"283","author":"Barlow","year":"2000","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jad.2012.09.023_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-0327(03)00043-0","article-title":"Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorder","volume":"80","author":"Berger","year":"2004","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2012.09.023_bib4","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4088\/JCP.v69n0810","article-title":"Generalizability of clinical trial results for major depression to community samples: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"69","author":"Blanco","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.drugalcdep.2008.05.002","article-title":"Generalizability of clinical trials for alcohol dependence to community samples","volume":"98","author":"Blanco","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jad.2012.09.023_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4088\/JCP.08m04506yel","article-title":"Generalizability of the results of efficacy trials in first-episode schizophrenia: comparisons between subgroups of participants of the European first episode schizophrenia trial (EUFEST)","volume":"71","author":"Boter","year":"2010","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib7","doi-asserted-by":"crossref","first-page":"790","DOI":"10.15288\/jsa.1999.60.790","article-title":"The Spanish alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population","volume":"60","author":"Canino","year":"1999","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.jad.2012.09.023_bib8","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/archpsyc.1984.01790230064010","article-title":"The clinician\u2019s illusion","volume":"41","author":"Cohen","year":"1984","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/ajp.152.5.683","article-title":"Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone","volume":"152","author":"de Beurs","year":"1995","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/heapro\/dah211","article-title":"Behavior change intervention research in community settings: how generalizable are the results?","volume":"19","author":"Dzewaltowski","year":"2004","journal-title":"Health Promotion International"},{"key":"10.1016\/j.jad.2012.09.023_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-0327(92)90094-M","article-title":"The galway study of panic disorder. I: Clomipramine and lofepramine in DSM III-R panic disorder: a placebo controlled trial","volume":"25","author":"Fahy","year":"1992","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2012.09.023_bib12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1600-0447.1997.tb09636.x","article-title":"Overcoming resistance to exposure in panic disorder with agoraphobia","volume":"95","author":"Fava","year":"1997","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jad.2012.09.023_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1192\/bjp.188.4.305","article-title":"Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review","volume":"188","author":"Furukawa","year":"2006","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib14","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1176\/appi.ps.60.11.1439","article-title":"What did STAR\u204eD teach us? Results from a large-scale, practical, clinical trial for patients with depression","volume":"60","author":"Gaynes","year":"2009","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jad.2012.09.023_bib15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4088\/JCP.v57n1105","article-title":"The infrequency of \u201cpure culture\u201d diagnoses among the anxiety disorders","volume":"57","author":"Goldenberg","year":"1996","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.drugalcdep.2004.02.004","article-title":"The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991\u20131992 and 2001\u20132002","volume":"74","author":"Grant","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jad.2012.09.023_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0376-8716(03)00070-X","article-title":"The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample","volume":"71","author":"Grant","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jad.2012.09.023_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0376-8716(95)01134-K","article-title":"The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample","volume":"39","author":"Grant","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jad.2012.09.023_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00406-003-0449-y","article-title":"Associations between anxiety disorders and physical illness","volume":"253","author":"Harter","year":"2003","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.jad.2012.09.023_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0376-8716(97)01332-X","article-title":"The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample","volume":"44","author":"Hasin","year":"1997","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jad.2012.09.023_bib21","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/archpsyc.64.7.830","article-title":"Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"64","author":"Hasin","year":"2007","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib22","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/da.21937","article-title":"Generalizability of clinical trial results for generalized anxiety disorder to community samples","volume":"29","author":"Hoertel","year":"2012","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.jad.2012.09.023_bib23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.15288\/jsad.2008.69.757","article-title":"Subject eligibility criteria can substantially influence the results of alcohol-treatment outcome research","volume":"69","author":"Humphreys","year":"2008","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.jad.2012.09.023_bib24","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1530-0277.2007.00391.x","article-title":"Influence of subject eligibility criteria on compliance with National Institutes of Health guidelines for inclusion of women, minorities, and children in treatment research","volume":"31","author":"Humphreys","year":"2007","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.jad.2012.09.023_bib25","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/j.1360-0443.2005.01175.x","article-title":"Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970\u201398","volume":"100","author":"Humphreys","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.jad.2012.09.023_bib26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/070674379504000406","article-title":"Clomipramine treatment and behaviour therapy with agoraphobic women","volume":"40","author":"Johnston","year":"1995","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib27","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4088\/JCP.v63n0904","article-title":"A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone","volume":"63","author":"Kampman","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/01.jcp.0000161497.73514.80","article-title":"Effect of study criteria on recruitment and generalizability of the results","volume":"25","author":"Khan","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2012.09.023_bib29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/tc.2010.038703","article-title":"How generalisable to community samples are clinical trial results for treatment of nicotine dependence: a comparison of common eligibility criteria with respondents of a large representative general population survey","volume":"20","author":"Le Strat","year":"2011","journal-title":"Tobacco Control"},{"key":"10.1016\/j.jad.2012.09.023_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/schbul\/sbm159","article-title":"Methodological issues in current antipsychotic drug trials","volume":"34","author":"Leucht","year":"2008","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jad.2012.09.023_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1192\/bjp.174.3.205","article-title":"Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia","volume":"174","author":"Loerch","year":"1999","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archpsyc.1983.01790020047004","article-title":"Imipramine and brief therapists-aided exposure in agoraphobics having self-exposure homework","volume":"40","author":"Marks","year":"1983","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/comp.2002.30803","article-title":"Predictors of entering a long-term drug treatment study of panic disorder","volume":"43","author":"Mavissakalian","year":"2002","journal-title":"Comprehensive Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib34","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1192\/bjp.143.4.348","article-title":"Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice","volume":"143","author":"Mavissakalian","year":"1983","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib35","first-page":"117","article-title":"Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine","volume":"47","author":"Mavissakalian","year":"1986","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1465-3362.2009.00096.x","article-title":"Ineligibility and refusal to participate in randomised trials of treatments for drug dependence","volume":"29","author":"Melberg","year":"2010","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jad.2012.09.023_bib37","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1192\/bjp.167.3.374","article-title":"Paroxetine in the treatment of panic disorder. a randomised, double-blind, placebo-controlled study","volume":"167","author":"Oehrberg","year":"1995","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.drugalcdep.2010.04.009","article-title":"Generalizability of clinical trials for cannabis dependence to community samples","volume":"111","author":"Okuda","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jad.2012.09.023_bib39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0887-6185(96)00008-4","article-title":"Fluvoxamine, placebo, and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia","volume":"10","author":"Sharp","year":"1996","journal-title":"Journal of Anxiety Disorders"},{"key":"10.1016\/j.jad.2012.09.023_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archpsyc.1980.01780140053006","article-title":"Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms","volume":"37","author":"Sheehan","year":"1980","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/(SICI)1099-0879(199606)3:2<86::AID-CPP91>3.0.CO;2-3","article-title":"Panic management, trazodone and a combination of both in the treatment of panic disorder","volume":"3","author":"Spinhoven","year":"1996","journal-title":"Clinical Psychology and Psychotherapy"},{"key":"10.1016\/j.jad.2012.09.023_bib42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-1781(00)00154-2","article-title":"Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study","volume":"94","author":"Stein","year":"2000","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.jad.2012.09.023_bib43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0005-7967(85)90011-7","article-title":"Combined pharmacological and behavioral treatment for agoraphobia","volume":"23","author":"Telch","year":"1985","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jad.2012.09.023_bib44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1192\/bjp.185.2.93","article-title":"Pharmaco-epidemiology: what do (and don\u2019t) we know about utilisation and impact of psychotropic medications in real-life conditions?","volume":"185","author":"Verdoux","year":"2004","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1740774509102563","article-title":"Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?","volume":"6","author":"Weisberg","year":"2009","journal-title":"Clinical Trials"},{"key":"10.1016\/j.jad.2012.09.023_bib51","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/archpsyc.1996.01830080041008","article-title":"Does brief dynamic psychotherapy reduce the relapse rate of panic disorder?","volume":"53","author":"Wiborg","year":"1996","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib46","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1037\/0022-006X.69.6.875","article-title":"A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies","volume":"69","author":"Westen","year":"2001","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.jad.2012.09.023_bib47","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1176\/appi.ajp.162.7.1370","article-title":"Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial","volume":"162","author":"Zimmerman","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib48","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1176\/appi.ajp.159.3.469","article-title":"Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?","volume":"159","author":"Zimmerman","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archpsyc.1980.01780140065007","article-title":"Treatment of agoraphobia with group exposure in vivo and imipramine","volume":"37","author":"Zitrin","year":"1980","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2012.09.023_bib50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archpsyc.1983.01790020019002","article-title":"Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo","volume":"40","author":"Zitrin","year":"1983","journal-title":"Archives of General Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032712006556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032712006556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T03:25:47Z","timestamp":1542684347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032712006556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0165032712006556"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2012.09.023","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are subjects in treatment trials of panic disorder representative of patients in routine clinical practice? Results from a national sample","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2012.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}